F18.94 Inhalant use, unspecified with inhalant-induced mood disorder

Name of the Condition

• Common Name: Inhalant Use Disorder with Inhalant-Induced Mood Disorder
• Medical Term: Inhalant use, unspecified with inhalant-induced mood disorder

Summary

Inhalant use, unspecified with inhalant-induced mood disorder, refers to the misuse of inhalants—substances that produce chemical vapors—for their psychoactive effects, accompanied by a mood disorder directly caused by inhalant use. This condition involves the intentional inhalation of substances like glue, paint thinners, or aerosols, which can lead to acute intoxication, dependence, or other substance-related health issues. Inhalant use may result in significant physical and psychological harm, affecting an individual's health and daily functioning.

Causes

Inhalant use is primarily driven by the repeated misuse of inhalants for their psychoactive effects. Inhalants are often everyday household or industrial products, such as glue, paint thinners, aerosols, or solvents. The misuse of these substances can lead to dependence and related health issues, including mood disorders.

Risk Factors

• Adolescents and young adults are more likely to experiment with inhalants.
• Individuals with a history of substance abuse or mental health disorders.
• Accessibility to inhalant products.
• Lack of proper supervision or guidance.

Symptoms

• Intense cravings or compulsive inhalant use.
• Coordination problems, dizziness, or lethargy.
• Unexplained behavioral changes such as aggression or mood swings.
• Cognitive impairment.
• Persistent mood disturbances (e.g., depression, anxiety) linked to inhalant use.

Diagnosis

Diagnosis involves a comprehensive evaluation of the patient's history, including patterns of inhalant use and associated mood symptoms. Clinical assessment focuses on identifying the temporal relationship between inhalant exposure and mood changes, ruling out other causes of mood disorders. Laboratory tests or imaging may be used to assess physical health impacts, while psychiatric evaluation confirms the presence of an inhalant-induced mood disorder.

Treatment Options

Treatment typically includes cessation of inhalant use, often supported by behavioral therapies (e.g., cognitive-behavioral therapy) to address dependence and mood symptoms. Pharmacotherapy may be used to manage mood disorders, and supportive care addresses withdrawal or acute effects. Long-term follow-up ensures sustained recovery and mental health stability.

Prognosis and Follow-Up

Prognosis depends on the severity of inhalant use and the response to treatment. Early intervention improves outcomes, but chronic use may lead to persistent mood symptoms or cognitive impairment. Regular follow-up with healthcare providers monitors progress, adjusts treatment, and addresses relapse risks.

Complications

• Worsening of mood disorders (e.g., depression, anxiety).
• Cognitive decline or neurological damage.
• Respiratory or organ damage from chronic inhalant use.
• Increased risk of accidents or injuries due to impaired judgment.

Lifestyle & Prevention

• Avoiding exposure to inhalants and educating about their risks.
• Seeking healthy coping mechanisms for stress or mental health concerns.
• Encouraging open communication with healthcare providers about substance use.
• Promoting supervised environments for at-risk populations (e.g., adolescents).

When to Seek Professional Help

Seek help if inhalant use is suspected, or if mood symptoms (e.g., persistent sadness, anxiety, or irritability) interfere with daily life. Immediate medical attention is needed for acute intoxication, severe mood disturbances, or signs of overdose.

Tips for Medical Coders

Document the presence of inhalant use and the specific inhalant-induced mood disorder to support code F18.94. Ensure clinical notes clearly link mood symptoms to inhalant exposure, and specify if the mood disorder is a direct result of substance use. Include details on the nature and duration of symptoms for accurate coding.